|
Since the device has not been returned for analysis, no product failure analysis can be conducted, and no determination of possible contributing factors can be made.As such, the investigation will be closed.If the complaint device is received in the future, the investigation will be reopened and conducted as appropriate.A manufacturing record evaluation (mre) was performed, and no anomalies were found related to this complaint.In addition, the mre verifies that the device was manufactured in accordance with documented specification and procedures.Mentor is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which mentor has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, mentor, or its employees that the report constitutes an admission that the device, mentor, or its employees caused or contributed to the potential event described in this report.If certain information is unknown, not available or does not apply, the section/field of the form is left blank.Reason for device explant and/or reoperation: deflation.Manufacturer¿s reference number: (b)(4).
|
|
It was reported that a patient underwent a breast reconstruction primary with mentor cpx 4 breast tissue expanders with suture tabs and experienced bilateral deflation post-operatively, which was confirmed during a physical exam.As a result, the patient is scheduled for removal on (b)(6) 2025.The impacted product in this complaint is intended for temporary subcutaneous or submuscular implantation and is not intended for use beyond six months.The reported implantation/explantation dates suggests an off-label use of the device.This report is for the right breast prosthesis.
|